[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $rhhbys $RHHBY sees increased social media activity with positive sentiment around gene therapy and oncology research. Engagements are up, indicating growing interest in the cryptocurrency. ### About $rhhbys A cryptocurrency. ### Insights [#](/topic/$rhhbys/insights) - $rhhbys mentions hit X which is XXX% higher than it's daily average. - $rhhbys creators hit X which is XXX% higher than it's daily average. ### Engagements: XXX [#](/topic/$rhhbys/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$rhhbys/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XX **1 Week**: XXXXX +17,403% **1 Month**: XXX -XX% **1-Year High**: XXXXX on 2025-09-03 **1-Year Low**: X on 2025-06-16 | Social Network | X | | -------------- | - | | Engagements | XXX | ### Mentions: X [#](/topic/$rhhbys/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$rhhbys/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1-Year High**: X on 2025-09-30 **1-Year Low**: X on 2025-05-01 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$rhhbys/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$rhhbys/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $rhhbys in the last XX hours which is up XX% from X in the previous XX hours **Daily Average**: X **1-Year High**: X on 2025-09-30 **1-Year Low**: X on 2025-05-01 **Top assets mentioned** In the posts about $rhhbys in the last XX hours [Moderna Inc (MRNA)](/topic/$mrna) **Top topics mentioned** In the posts about $rhhbys in the last XX hours [jacob](/topic/jacob), [$mrna](/topic/$mrna), [stocks healthcare](/topic/stocks-healthcare), [$legn](/topic/$legn), [$vrdn](/topic/$vrdn), [$rhhby](/topic/$rhhby), [ted](/topic/ted), [trails](/topic/trails), [niche](/topic/niche), [$qures](/topic/$qures), [$regns](/topic/$regns), [approved](/topic/approved) ### Top Social Posts [#](/topic/$rhhbys/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$VRDN Jefferies w XX PT based on competitor $RHHBY not competitive results Enrolment in both trails completed with data in h1'25 TED market is 4B or 8B if early stages are included $VRDN MC is 2B with 560M cash" [X Link](https://x.com/Andre_AGTC/status/1979552219230872010) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-10-18T14:16Z 6072 followers, 1702 engagements "It looks like AAV gene therapy is finding its niche: local delivery of relatively low doses (E10-E12 total vg) in tissues as contained as possible. Recent clinical wins by $QURE's AMT-130 (intra-parenchymal Huntington's) and $REGN's DB-OTO (intracochlear inherited deafness) support this trend. These follow prior approved drugs like $RHHBY's Luxturna (subretinal LCA2) and $PTCT's Upstaza (intra-parenchymal AADC deficiency) also delivered locally. $NVS' Zolgensma is a special case -- although delivered systemically at relatively high doses the infant BBB remains permissive allowing efficient" [X Link](https://x.com/GerardCaelles/status/1977771288660791721) [@GerardCaelles](/creator/x/GerardCaelles) 2025-10-13T16:19Z 1098 followers, 13.9K engagements "Interesting take on the FcRH5 landscape which seems to be one of $RHHBY's main oncology R&D areas of interest. $MRNA & $LEGN active here" [X Link](https://x.com/JacobPlieth/status/1970769553572454869) [@JacobPlieth](/creator/x/JacobPlieth) 2025-09-24T08:37Z 30.9K followers, 4482 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$RHHBY sees increased social media activity with positive sentiment around gene therapy and oncology research. Engagements are up, indicating growing interest in the cryptocurrency.
A cryptocurrency.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
1 Week: XXXXX +17,403%
1 Month: XXX -XX%
1-Year High: XXXXX on 2025-09-03
1-Year Low: X on 2025-06-16
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-09-30
1-Year Low: X on 2025-05-01
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $rhhbys in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
1-Year High: X on 2025-09-30
1-Year Low: X on 2025-05-01
Top assets mentioned In the posts about $rhhbys in the last XX hours
Top topics mentioned In the posts about $rhhbys in the last XX hours
jacob, $mrna, stocks healthcare, $legn, $vrdn, $rhhby, ted, trails, niche, $qures, $regns, approved
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$VRDN Jefferies w XX PT based on competitor $RHHBY not competitive results Enrolment in both trails completed with data in h1'25 TED market is 4B or 8B if early stages are included $VRDN MC is 2B with 560M cash"
X Link @Andre_AGTC 2025-10-18T14:16Z 6072 followers, 1702 engagements
"It looks like AAV gene therapy is finding its niche: local delivery of relatively low doses (E10-E12 total vg) in tissues as contained as possible. Recent clinical wins by $QURE's AMT-130 (intra-parenchymal Huntington's) and $REGN's DB-OTO (intracochlear inherited deafness) support this trend. These follow prior approved drugs like $RHHBY's Luxturna (subretinal LCA2) and $PTCT's Upstaza (intra-parenchymal AADC deficiency) also delivered locally. $NVS' Zolgensma is a special case -- although delivered systemically at relatively high doses the infant BBB remains permissive allowing efficient"
X Link @GerardCaelles 2025-10-13T16:19Z 1098 followers, 13.9K engagements
"Interesting take on the FcRH5 landscape which seems to be one of $RHHBY's main oncology R&D areas of interest. $MRNA & $LEGN active here"
X Link @JacobPlieth 2025-09-24T08:37Z 30.9K followers, 4482 engagements
/topic/$rhhbys